Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Traws Pharma (TRAW) Minority Interest (2016 - 2018)

Traws Pharma (TRAW) has disclosed Minority Interest for 6 consecutive years, with $830000.0 as the latest value for Q1 2018.

  • On a quarterly basis, Minority Interest changed 0.0% to $830000.0 in Q1 2018 year-over-year; TTM through Mar 2018 was $830000.0, a 0.0% change, with the full-year FY2017 number at $830000.0, changed 0.0% from a year prior.
  • Minority Interest was $830000.0 for Q1 2018 at Traws Pharma, roughly flat from $830000.0 in the prior quarter.
  • In the past five years, Minority Interest ranged from a high of $874000.0 in Q4 2014 to a low of $394000.0 in Q3 2014.
  • A 5-year average of $761823.5 and a median of $830000.0 in 2015 define the central range for Minority Interest.
  • Biggest YoY gain for Minority Interest was 110.66% in 2015; the steepest drop was 5.03% in 2015.
  • Traws Pharma's Minority Interest stood at $874000.0 in 2014, then fell by 5.03% to $830000.0 in 2015, then changed by 0.0% to $830000.0 in 2016, then changed by 0.0% to $830000.0 in 2017, then changed by 0.0% to $830000.0 in 2018.
  • Per Business Quant, the three most recent readings for TRAW's Minority Interest are $830000.0 (Q1 2018), $830000.0 (Q4 2017), and $830000.0 (Q3 2017).